Asepsis announces the USPTO grant of U.S. Patent 9,302,050 for its combinatorial, Calibrated Drug Delivery™ (CDD) platform. The 050 patent continuation further enhances the reconstitution aspects of the CDD injection kit. The completed platform provides the ability for a medicinal injection to be reconstituted and administered via multiple prescribed dosage techniques or patient specific characteristics, without any calculation procedures.
